Zafrens Inc.

SAN DIEGO, CA · Founded 2021 · Biotech · Private

Z-Screen: a ultra-high-throughput screening plate with 50,000-200,000 wells and integrated mRNA sequencing capability enabling single-cell phenotype-genotype correlation

Claim this profile

Follows are private to you and power your alerts

Updated · zafrens.com

Sector
Biotech
Headquarters
SAN DIEGO, CA
Founded
2021
Latest Form D
$6.2M, Jan 2022
Total capital
$6.2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$6.2M
1 Form D · last Jan 2022
57 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
16 pending · first 2026
Rank in peer group#7 of 22

Capital timeline

2022FEDERAL ↑EQUITY ↓Cumulative $6.2M1st Form D$6.2M
2022FEDERAL ↑EQUITY ↓Cumulative $6.2M1st Form D$6.2M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$6.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 22 peers

Line = median

Biotech · Instrument

  • Granted patents#7 · top 32%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Kandaswamy VijayanResearcherExecutive Officer, DirectorLinked by 1 patent

What it has protected

USPTO · 1 granted of 17
  • GrantedPerturbation Beads for Use in AssaysUSPTOUS 12,577,556
  • PendingHigh Throughput Assays for Identifying the Biological Response of a CellUSPTOApplication 19035214
  • PendingCapture Beads for Use in AssaysUSPTOApplication 18734732
Show all 17 patent records
  • Perturbation Beads for Use in AssaysMar 17, 2026 · US 12,577,556Granted
  • High Throughput Assays for Identifying the Biological Response of a CellJul 24, 2025 · Application 19035214Pending
  • Capture Beads for Use in AssaysOct 31, 2024 · Application 18734732Pending
  • High Throughput Single Cell Based Assay For Capturing Genomic Information For Functional And Imaging Analysis And Methods Of UseSep 12, 2024 · Application 18195049Pending
  • Perturbation Beads For Use In AssaysApplication PCTUS2024032022Pending
  • Cell Transfer Component For Multi-well Assay DeviceApplication PCTUS2024023594Pending
  • High Throughput Assays for Identifying the Biological Response of a CellApplication 63624167Pending
  • Capture Beads for Use in AssaysApplication 63624181Pending
  • Systems For Employing An Encoded Micro-component To Identify A CellApplication 63494628Pending
  • Assay Device For Employing An Encoded Micro-component To Identify A CellApplication 63494621Pending
  • Transfer Device For Employing An Encoded Micro-component To Identify A CellApplication 63494636Pending
  • High Throughput Single Cell Based Assay For Capturing Genomic Information For Functional And Imaging Analysis And Methods Of UseApplication 63339782Pending
  • Reversible Transfer Devices And Uses ThereofApplication PCTUS2025048087Pending
  • Cell Transfer Component for Multi-Well Assay DeviceApplication 19473058Pending
  • Capture Beads For Use In AssaysApplication PCTUS2025012691Pending
  • Reversible Transfer Devices And Uses ThereofApplication 63699739Pending
  • Capture Beads For Use In AssaysApplication PCTUS2024032014Pending
  • BioLineRx Ltd.Similar federal contract value in Biotech · null in contracts
  • NANOPHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
  • Nerio TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Invenra Inc.Similar federal contract value in Biotech · null in contracts
  • LEUKOGENE THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
  • CERTICHEM, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .